Showing 10,921 - 10,940 results of 13,723 for search '(( a ((teer decrease) OR (linear decrease)) ) OR ( a ((greatest decrease) OR (largest decrease)) ))', query time: 0.57s Refine Results
  1. 10921

    Table_1_Assessing the Relationship Between Leukocyte Telomere Length and Cancer Risk/Mortality in UK Biobank and TCGA Datasets With the Genetic Risk Score and Mendelian Randomizati... by Yixin Gao (3182019)

    Published 2020
    “…</p>Results<p>In the UK Biobank dataset, we found that the GRS of leukocyte telomere length was associated with a decreased risk of nine types of cancer (i.e., significant association with multiple myeloma, chronic lymphocytic leukemia, kidney/renal cell cancer, bladder cancer, malignant melanoma, basal cell carcinoma, and prostate cancer and suggestive association with sarcoma/fibrosarcoma and Hodgkin’s lymphoma/Hodgkin’s disease). …”
  2. 10922

    Table 4_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... by Zachary D. Wallen (19986522)

    Published 2024
    “…Further, certain modules of genes with co-occurring genomic alterations had dose-dependent relationships with histology and increasing or decreasing levels of PD-L1 and TMB, suggesting a complex relationship between PD-L1, TMB, and genomic alterations in these gene modules.…”
  3. 10923

    Table_1_Strain level and comprehensive microbiome analysis in inflammatory bowel disease via multi-technology meta-analysis identifies key bacterial influencers of disease.docx by Jayamary Divya Ravichandar (13957323)

    Published 2022
    “…Objective<p>Inflammatory bowel disease (IBD) is a heterogenous disease in which the microbiome has been shown to play an important role. …”
  4. 10924

    Table 1_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... by Zachary D. Wallen (19986522)

    Published 2024
    “…Further, certain modules of genes with co-occurring genomic alterations had dose-dependent relationships with histology and increasing or decreasing levels of PD-L1 and TMB, suggesting a complex relationship between PD-L1, TMB, and genomic alterations in these gene modules.…”
  5. 10925

    Table_3_Strain level and comprehensive microbiome analysis in inflammatory bowel disease via multi-technology meta-analysis identifies key bacterial influencers of disease.xlsx by Jayamary Divya Ravichandar (13957323)

    Published 2022
    “…Objective<p>Inflammatory bowel disease (IBD) is a heterogenous disease in which the microbiome has been shown to play an important role. …”
  6. 10926

    Table_2_Strain level and comprehensive microbiome analysis in inflammatory bowel disease via multi-technology meta-analysis identifies key bacterial influencers of disease.xlsx by Jayamary Divya Ravichandar (13957323)

    Published 2022
    “…Objective<p>Inflammatory bowel disease (IBD) is a heterogenous disease in which the microbiome has been shown to play an important role. …”
  7. 10927

    Table 5_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... by Zachary D. Wallen (19986522)

    Published 2024
    “…Further, certain modules of genes with co-occurring genomic alterations had dose-dependent relationships with histology and increasing or decreasing levels of PD-L1 and TMB, suggesting a complex relationship between PD-L1, TMB, and genomic alterations in these gene modules.…”
  8. 10928

    Image_8_Strain level and comprehensive microbiome analysis in inflammatory bowel disease via multi-technology meta-analysis identifies key bacterial influencers of disease.TIFF by Jayamary Divya Ravichandar (13957323)

    Published 2022
    “…Objective<p>Inflammatory bowel disease (IBD) is a heterogenous disease in which the microbiome has been shown to play an important role. …”
  9. 10929

    Image_4_Strain level and comprehensive microbiome analysis in inflammatory bowel disease via multi-technology meta-analysis identifies key bacterial influencers of disease.TIFF by Jayamary Divya Ravichandar (13957323)

    Published 2022
    “…Objective<p>Inflammatory bowel disease (IBD) is a heterogenous disease in which the microbiome has been shown to play an important role. …”
  10. 10930

    Table_4_Strain level and comprehensive microbiome analysis in inflammatory bowel disease via multi-technology meta-analysis identifies key bacterial influencers of disease.xlsx by Jayamary Divya Ravichandar (13957323)

    Published 2022
    “…Objective<p>Inflammatory bowel disease (IBD) is a heterogenous disease in which the microbiome has been shown to play an important role. …”
  11. 10931

    Image_15_Strain level and comprehensive microbiome analysis in inflammatory bowel disease via multi-technology meta-analysis identifies key bacterial influencers of disease.TIFF by Jayamary Divya Ravichandar (13957323)

    Published 2022
    “…Objective<p>Inflammatory bowel disease (IBD) is a heterogenous disease in which the microbiome has been shown to play an important role. …”
  12. 10932

    Image_12_Strain level and comprehensive microbiome analysis in inflammatory bowel disease via multi-technology meta-analysis identifies key bacterial influencers of disease.TIFF by Jayamary Divya Ravichandar (13957323)

    Published 2022
    “…Objective<p>Inflammatory bowel disease (IBD) is a heterogenous disease in which the microbiome has been shown to play an important role. …”
  13. 10933

    Image_1_Strain level and comprehensive microbiome analysis in inflammatory bowel disease via multi-technology meta-analysis identifies key bacterial influencers of disease.TIFF by Jayamary Divya Ravichandar (13957323)

    Published 2022
    “…Objective<p>Inflammatory bowel disease (IBD) is a heterogenous disease in which the microbiome has been shown to play an important role. …”
  14. 10934

    Table 2_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... by Zachary D. Wallen (19986522)

    Published 2024
    “…Further, certain modules of genes with co-occurring genomic alterations had dose-dependent relationships with histology and increasing or decreasing levels of PD-L1 and TMB, suggesting a complex relationship between PD-L1, TMB, and genomic alterations in these gene modules.…”
  15. 10935

    Image_11_Strain level and comprehensive microbiome analysis in inflammatory bowel disease via multi-technology meta-analysis identifies key bacterial influencers of disease.TIFF by Jayamary Divya Ravichandar (13957323)

    Published 2022
    “…Objective<p>Inflammatory bowel disease (IBD) is a heterogenous disease in which the microbiome has been shown to play an important role. …”
  16. 10936

    Image_9_Strain level and comprehensive microbiome analysis in inflammatory bowel disease via multi-technology meta-analysis identifies key bacterial influencers of disease.TIFF by Jayamary Divya Ravichandar (13957323)

    Published 2022
    “…Objective<p>Inflammatory bowel disease (IBD) is a heterogenous disease in which the microbiome has been shown to play an important role. …”
  17. 10937

    Image_2_Strain level and comprehensive microbiome analysis in inflammatory bowel disease via multi-technology meta-analysis identifies key bacterial influencers of disease.TIFF by Jayamary Divya Ravichandar (13957323)

    Published 2022
    “…Objective<p>Inflammatory bowel disease (IBD) is a heterogenous disease in which the microbiome has been shown to play an important role. …”
  18. 10938

    Table_1_Sirt1 Promotes the Restoration of Hepatic Progenitor Cell (HPC)-Mediated Liver Fatty Injury in NAFLD Through Activating the Wnt/β-Catenin Signal Pathway.DOCX by Qinjin Li (11838788)

    Published 2021
    “…Glycogen PAS staining demonstrated that Sirt1 OE promoted WB-F344 cells to differentiate into mature hepatocytes with glycogen synthesis ability, while Sirt1 inhibitor EX527 or Wnt/β-catenin pathway inhibitor HF535 decreased glycogen positive cells. Together, our data suggested that Sirt1 plays a vital role in activating HPCs to repair fatty liver injury or promote liver regeneration through the Wnt/β-catenin signal pathway in NAFLD, which might provide a new strategy for fatty liver injury or NAFLD therapy.…”
  19. 10939

    Image_10_Strain level and comprehensive microbiome analysis in inflammatory bowel disease via multi-technology meta-analysis identifies key bacterial influencers of disease.TIFF by Jayamary Divya Ravichandar (13957323)

    Published 2022
    “…Objective<p>Inflammatory bowel disease (IBD) is a heterogenous disease in which the microbiome has been shown to play an important role. …”
  20. 10940

    Image_5_Strain level and comprehensive microbiome analysis in inflammatory bowel disease via multi-technology meta-analysis identifies key bacterial influencers of disease.TIFF by Jayamary Divya Ravichandar (13957323)

    Published 2022
    “…Objective<p>Inflammatory bowel disease (IBD) is a heterogenous disease in which the microbiome has been shown to play an important role. …”